U.S. Senate · 118th Congress · S. 1961
Pharmaceutical Supply Chain Risk Assessment Act of 2023
A bill to require an interagency risk assessment of the pharmaceutical supply chain to identify and mitigate health and national security risks, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Gary C. PetersD-MI
- Introduced
- June 13, 2023, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (1)
1 Republican. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Joni ErnstR-IA